Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of the Parse GigaLab™ to scale single cell ...
The compromise between sequencing speed and capacity has impacted research for years. To combat this conundrum, in 2018, MGI launched the high-throughput sequencer, DNBSEQ-T7 that can output 7Tb of ...
The partnership marks a global agreement to jointly develop automation scripts for Ultima Genomics' sample preparation and amplification workflows for use on Hamilton's Microlab STAR platform. The ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall Wace and Janus ...
Ultima Genomics, and next generation Solaris 2.0 workflows, together, these advancements move Ultima closer to its vision of delivering sequencing at the necessary scale to drive the next era of ...
A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease Enzymatic conversion–mediated ...
In-situ multiomics is revolutionizing research in oncology, immunology and neurobiology. However, speed and throughput are major bottlenecks for these critical studies. Here, we present data from a ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results